Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedMC
Mayo Clinic
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
- Rounds participated in
- 6
- Confirmed lead rounds
- — 6 roles undisclosed
- New companies
- 6 First participation on record · 0 follow-on
- Funding in participating rounds
- $925.9M 6 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
6 in this selectionTechcyte
Provides AI-powered digital diagnostics for anatomic and clinical pathology
$15MUndisclosed
Role not disclosedSub-Q Bionics
Develops implantable lymphatic drainage system to manage lymphedema
$1.5MPre-Seed
Role not disclosedWHOOP
Provides wearable health monitoring and personalized health insights
$575MSeries G
Role not disclosedVitestro
Develops autonomous robotic phlebotomy devices for diagnostic blood collection
$70MSeries B
Role not disclosedOpenEvidence
Provides AI-powered medical search engine for clinicians
$250MSeries D
Role not disclosed